Last reviewed · How we verify

NCT06850948

Experiences of Healthcare for Autistic TGD Adults

Not yet recruiting Last updated 28 February 2025
What this trial tests

trial testing Qualitative in Autism Spectrum Disorder (ASD in 18 participants. Not yet recruiting.

Timeline
3 March 2025
Primary endpoint
7 September 2026
7 September 2026

Quick facts

Lead sponsorUniversity of Nottingham
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment18
Start date3 March 2025
Primary completion7 September 2026
Estimated completion7 September 2026

Drugs / interventions tested

Conditions studied

Sponsor

University of Nottingham

Who can join

18 and older, any sex, with Autism Spectrum Disorder (ASD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore the experiences of autistic gender diverse adults that have attempted or are attempting to access, have accessed or are currently accessing gender identity healthcare in the United Kingdom

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Qualitative

Trials testing the same drug.

Other recruiting trials for Autism Spectrum Disorder (ASD

Currently open trials in the same condition.

Other University of Nottingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06850948.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing